Y K Amdekar. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibiotics, Antitubercular/therapeutic useAntitubercular Agents/therapeutic useChemopreventionHumansIndiaIsoniazid/therapeutic useMycobacterium tuberculosis/drug effectsMycobacterium tuberculosis/geneticsPatient ComplianceRifampin/therapeutic useTuberculosis, Multidrug-Resistant/diagnosisTuberculosis, Multidrug-Resistant/drug therapyTuberculosis, Multidrug-Resistant/etiologyTuberculosis, Multidrug-Resistant/geneticsTuberculosis, Multidrug-Resistant/prevention & control
Substances： See more » Antibiotics, AntitubercularAntitubercular AgentsIsoniazidRifampin
Year: 1998 PMID： 10216564
Source DB: PubMed Journal: Indian Pediatr ISSN： 0019-6061 Impact factor: 1.411